FindTrial
Sign In

A STUDY COMPARING TWO DRUGS DEXMEDETOMIDINE AND CLONIDINE AS ADJUVANTS TO INTRATHECAL 0.5 PERCENT HYPERBARIC BUPIVACAINE IN INFRAUMBILICAL SURGERIES

COMPARISON OF DEXMEDETOMIDINE VERSUS CLONIDINE AS AN ADJUVANT TO INTRATHECAL 0.5 PERCENT HYPERBARIC BUPIVACAINE HEAVY IN INFRAUMBILICAL SURGERIES, A PROSPECTIVE RANDOMIZED DOUBLE BLIND STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108048
Enrollment
120
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K353- Acute appendicitis with localizedperitonitis Health Condition 2: K402- Bilateral inguinal hernia, withoutobstruction or gangrene Health Condition 3: K429- Umbilical hernia without obstruction or gangrene Health Condition 4: N819- Female genital prolapse, unspecified Health Condition 5: K409- Unilateral inguinal hernia, without obstruction or gangrene Health Condition 6: M161- Unilateral primary osteoarthritisof hip Health Condition 7: M171- Unilateral primary osteoarthr

Interventions

Intervention1: Injection 0.5% Hyperbaric bupivacaine 15 mg: Injection 0.5% hyperbaric Bupivacaine 15 mg administered intrathecally at L3 L4 or L4 L5 interspace under strict aseptic precautions Interv

Sponsors

Pacific Medical College and Hospital, Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either sex of age group 18-60 year ASA physical status I and II Patient posted for elective infraumblical surgeries Patient giving valid written and informed consent

Exclusion criteria

Exclusion criteria: Patient giving negative consent PPatient with contraindication to spinal anaesthesia Allergy to either drug used in the study Patient posted for emergency surgery

Design outcomes

Primary

MeasureTime frame
To compare onset , duration of sensory and motor block and post operative analgesiaTimepoint: 24 Hrs—

Secondary

MeasureTime frame
To study hemodynamic parameter and side effect if anyTimepoint: 24 Hrs—

Countries

India

Contacts

Public ContactDr Prakash Chandra Audichya

Pacific Medical College and Hospital

prakash.audichya10@gmail.com9929721889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026